GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tracking a targeted cancer therapy in real patients
Disease control OngoingThis study is observing how well the approved cancer drug Lutathera works for adults with advanced neuroendocrine tumors of the gut or pancreas in real-world medical practice. Researchers are following 164 patients for up to 3 years to see how long the treatment keeps the cancer …
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major study aims to map the best path for treating rare tumors
Knowledge-focused OngoingThis study aims to understand how different treatment sequences affect the quality of life and symptoms of people with neuroendocrine tumors (NETs). Researchers will follow over 2,500 patients for up to five years, linking their survey answers about their health and treatment exp…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC